Man Tong

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Idiopathic Pulmonary Fibrosis

Tyrosine Kinase

Top Venues

Cell death & disease

Cancer research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yunong Xie, Haofeng Wu, Yimiao He, Linglin Liu, Ianto Bosheng Huang, Lei Zhou, Cheuk-Yin Lin, Rainbow Wing-Hei Leung, Jia-Jian Loh, Terence Kin-Wah Lee, Jin Ding, Kwan Man, Stephianie Ma, Man Tong
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer. Cell death & disease 15 (2) (2024)
Yunong Xie, Haofeng Wu, Yimiao He, Linglin Liu, Ianto Bosheng Huang, Lei Zhou, Cheuk-Yin Lin, Rainbow Wing-Hei Leung, Jia-Jian Loh, Terence Kin-Wah Lee, Jin Ding, Kwan Man, Stephianie Ma, Man Tong
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer. Cell death & disease 15 (2) (2024)
Yunong Xie, Haofeng Wu, Yimiao He, Linglin Liu, Ianto Bosheng Huang, Lei Zhou, Cheuk-Yin Lin, Rainbow Wing-Hei Leung, Jia-Jian Loh, Terence Kin-Wah Lee, Jin Ding, Kwan Man, Stephianie Ma, Man Tong
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer. Cell death & disease 15 (2) (2024)
Yunong Xie, Haofeng Wu, Yimiao He, Linglin Liu, Ianto Bosheng Huang, Lei Zhou, Cheuk-Yin Lin, Rainbow Wing-Hei Leung, Jia-Jian Loh, Terence Kin-Wah Lee, Jin Ding, Kwan Man, Stephianie Ma, Man Tong
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer. Cell death & disease 15 (2) (2024)
Tin-Lok Wong, Jia-Jian Loh, Shixun Lu, Helen Y N Yan, Hoi Cheong Siu, Ren Xi, Dessy Chan, Max J F Kam, Lei Zhou, Man Tong, John A Copland, Leilei Chen, Jing-Ping Yun, Suet Yi Leung, Stephianie Ma
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. Nature communications 14 (1) (2023)
Tin-Lok Wong, Jia-Jian Loh, Shixun Lu, Helen Y N Yan, Hoi Cheong Siu, Ren Xi, Dessy Chan, Max J F Kam, Lei Zhou, Man Tong, John A Copland, Leilei Chen, Jing-Ping Yun, Suet Yi Leung, Stephianie Ma
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. Nature communications 14 (1) (2023)
Tin-Lok Wong, Jia-Jian Loh, Shixun Lu, Helen Y N Yan, Hoi Cheong Siu, Ren Xi, Dessy Chan, Max J F Kam, Lei Zhou, Man Tong, John A Copland, Leilei Chen, Jing-Ping Yun, Suet Yi Leung, Stephianie Ma
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. Nature communications 14 (1) (2023)
Yifei Wang, Man Tong
Protein Posttranslational Modification in Stemness Remodeling and Its Emerging Role as a Novel Therapeutic Target in Gastrointestinal Cancers. International journal of molecular sciences 24 (11) (2023)
Etienne Ho Kit Mok, Carmen Oi Ning Leung, Lei Zhou, Martina Mang Leng Lei, Hoi Wing Leung, Man Tong, Tin-Lok Wong, Eunice Yuen Ting Lau, Irene Oi Lin Ng, Jin Ding, Jing-Ping Yun, Jun Yu, Hui Lian Zhu, Chi Ho Lin, Dan Lindholm, Kit Sum Leung, Jonathan D Cybulski, David M Baker, Stephianie Ma, Terence Kin-Wah Lee
Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma. Cancer research 82 (17) (2022)
Yunong Xie, Stephianie Ma, Man Tong
Metabolic Plasticity of Cancer Stem Cells in Response to Microenvironmental Cues. Cancers 14 (21) (2022)
Nicole Pui Yu Ho, Carmen Oi Ning Leung, Tin-Lok Wong, Eunice Yuen Ting Lau, Martina Mang Leng Lei, Etienne Ho Kit Mok, Hoi Wing Leung, Man Tong, Irene Oi Lin Ng, Jing Ping Yun, Stephianie Ma, Terence Kin-Wah Lee
The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression. Cell death & disease 12 (2) (2021)
Feng Xu, Man Tong, Cindy S W Tong, Becky K C Chan, Hoi Yee Chu, Tin-Lok Wong, John H C Fong, Maggie S H Cheung, Kylie Hin-Man Mak, Lakhansing Pardeshi, Yuanhua Huang, Koon Ho Wong, Gigi C G Choi, Stephianie Ma, Alan S L Wong
A combinatorial CRISPR-Cas9 screen identifies ifenprodil as an adjunct to sorafenib for liver cancer treatment. Cancer research (2021)
Lei Zhou, Ken Ho Yu, Tin-Lok Wong, Zhao Zhang, Chun Ho Chan, Jane Hc Loong, Noelia Che, Hua Jian Yu, Kel Vin Tan, Man Tong, Elly S Ngan, Joshua Wk Ho, Stephianie Ma
Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression. Gut (2021)
Jia-Jian Loh, Tsz-Wai Li, Lei Zhou, Tin-Lok Wong, Xue Liu, Victor W S Ma, Chung-Mau Lo, Kwan Man, Terence Kin-Wah Lee, Wen Ning, Man Tong, Stephianie Ma
FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness. Cancer research 81 (22) (2021)
Hoi Wing Leung, Carmen Oi Ning Leung, Eunice Y Lau, Katherine Po Sin Chung, Etienne H Mok, Martina Mang Leng Lei, Rainbow Wing Hei Leung, Man Tong, Vincent W Keng, Cong Ma, Qian Zhao, Irene Oi Lin Ng, Stephianie Ma, Terence Kin-Wah Lee
EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma. Cancer research 81 (12) (2021)